KOL Perspectives: Upadacitinib for Rheumatoid Arthritis

Market: Pharmaceuticals and Healthcare

Global, 24 pages report, published by GlobalData

Report ThumbnailAugust-2018
KOL Perspectives: Upadacitinib for Rheumatoid Arthritis

Summary

This KOL Insight briefing focuses on perceptions of novel upadacitinib data in RA.

The briefing includes analysis of KOL opinion on the following topic areas -
- Efficacy & safety of upadacitinib in the SELECT COMPARE trial (csDMARD-IR patients)
- Efficacy & safety of upadacitinib as a monotherapy in SELECT MONOTHERAPY trial (MTX-IR patients)
- Views on dose response for upadacitinib

Key Highlights

- Majority of KOLs had a pos

Read More
  • Table of Contents
  • Executive Summary
  • Background
  • Research Panel Composition
  • Results & Implications
  • Appendix
Read More

Please select a license type

Share

Related Products

GlobalDataKOL Perspectives: Upadacitinib for Rheumatoid ArthritisProduct ThumbnailKOL Perspectives: Upadacitinib for Rheumatoid Arthritis, Industry ReportProduct #: 1190962
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved